MACK - Merrimack Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3133
Avg. Estimate-0.28-1.0336.28-5.44
Low Estimate-1.45-1.0335.19-7.62
High Estimate1.69-1.0338.38-4.26
Year Ago EPS-2.5-2.3-12.136.28
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3123
Avg. Estimate11MN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High Estimate33MN/AN/AN/A
Year Ago Sales61.24M25.91M144.27MN/A
Sales Growth (year/est)-82.00%N/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-2.08-1.1-1.37-1.88
EPS Actual-2.5-2.338.60.24
Difference-0.42-1.239.972.12
Surprise %-20.20%-109.10%2,917.50%112.80%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.28-1.0336.28-5.44
7 Days Ago-0.28-1.0336.28-5.44
30 Days Ago-1.36-1.0333.49-14.05
60 Days Ago-1.36-0.933.49-14.05
90 Days Ago-1.36033.43-13.92
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3N/A31
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesMACKIndustrySectorS&P 500
Current Qtr.88.80%N/AN/A0.22
Next Qtr.55.20%N/AN/A0.25
Current Year399.80%N/AN/A0.08
Next Year-115.00%N/AN/A0.12
Next 5 Years (per annum)5.60%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A